COST-EFFECTIVENESS ANALYSIS OF INSULIN DETEMIR VERSUS INSULIN NEUTRAL PROTAMINE HAGEDORN (NPH) IN PATIENTS WITH TYPE 1 DIABETES MELLITUS IN SPAIN

被引：0
|
作者：
Ramirez de Arellano, A. [1 ]
Lizan, L. [2 ]
Prades, M. [2 ]
Morales, C. [3 ]
De Luis, D. [4 ]
机构：
[1] Novo Nordisk Pharma SA, Madrid, Spain
[2] Outcomes 10, Castellon de La Plana, Spain
[3] Hosp Virgen de la Macarena, Seville, Spain
[4] Hosp Rio Hortega, Valladolid, Spain
来源：
VALUE IN HEALTH | 2014年 / 17卷 / 07期
关键词：
D O I：
暂无
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB64
引用
收藏
页码：A343 / A343
页数：1
相关论文
共 50 条
  • [1] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Morales, Cristobal
    de Luis, Daniel
    Ramirez de Arellano, Antonio
    Giovanna Ferrario, Maria
    Lizan, Luis
    DIABETES THERAPY, 2015, 6 (04) : 593 - 610
  • [2] Cost-Effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Spain
    Cristóbal Morales
    Daniel de Luis
    Antonio Ramírez de Arellano
    Maria Giovanna Ferrario
    Luis Lizán
    Diabetes Therapy, 2015, 6 : 593 - 610
  • [3] Cost-effectiveness Analysis of Insulin Detemir Compared to Neutral Protamine Hagedorn (NPH) in Patients with Type 1 and Type 2 Diabetes Mellitus in Portugal
    Cardoso, Cristina
    Ramirez de Arellano, Antonio
    Prades, Miriam
    Lizan, Luis
    JOURNAL OF DIABETES & METABOLISM, 2016, 7 (03)
  • [4] COMPARISON OF HYPOGLYCEMIA BETWEEN COMBINATION OF INSULIN DETEMIR AND ASPART WITH COMBINATION OF NPH (NEUTRAL PROTAMINE HAGEDORN) AND REGULAR INSULIN IN PATIENTS OF TYPE 1 DIABETES MELLITUS
    Hussain, Ibrar
    Ul Javed, Soud
    Abid, Ali Farhan
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (04): : 7488 - 7499
  • [5] Evaluating the cost-effectiveness of insulin detemir versus neutral protamine Hagedorn insulin in patients with type 1 or type 2 diabetes in the UK using a short-term modeling approach
    Pollock, Richard F.
    Chubb, Barrie
    Valentine, William J.
    Heller, Simon
    DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2018, 11 : 217 - 226
  • [6] Detemir versus Insulin Neutral Protamine Hagedorn for Diabetes Mellitus: A Comparative-Effectiveness, Randomized Controlled Trial
    Bartal, Michal Fishel
    Ward, Clara
    Blackwell, Sean C.
    Cornthwaite, Joycelyn A.
    Zhang, Caroline C.
    Refuerzo, Jerrie
    Pedroza, Claudia
    Lee, Kyung Hyun
    Chauhan, Suneet P.
    Sibai, Baha M.
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2021, 224 (02) : S21 - S22
  • [7] Neonatal and Maternal Outcomes of Insulin Detemir versus Neutral Protamine Hagedorn for Diabetes Mellitus in Pregnancy
    Bugazia, Seif
    Boshnaf, Mohamed
    Elbahnasawy, Mohammad
    Shehata, Mostafa
    Alqatati, Fadel
    Ragab, Khaled Mohamed
    Elsnhory, Ahmed Bostamy
    Elsayed, Sarah Makram
    Fathy, Mustafa Ali
    Nourelden, Anas Zakarya
    CURRENT WOMENS HEALTH REVIEWS, 2023, 19 (03) : 120 - 129
  • [8] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Permsuwan, Unchalee
    Chaiyakunapruk, Nathorn
    Dilokthornsakul, Piyameth
    Thavorn, Kednapa
    Saokaew, Surasak
    APPLIED HEALTH ECONOMICS AND HEALTH POLICY, 2016, 14 (03) : 281 - 292
  • [9] Long-Term Cost-Effectiveness of Insulin Glargine Versus Neutral Protamine Hagedorn Insulin for Type 2 Diabetes in Thailand
    Unchalee Permsuwan
    Nathorn Chaiyakunapruk
    Piyameth Dilokthornsakul
    Kednapa Thavorn
    Surasak Saokaew
    Applied Health Economics and Health Policy, 2016, 14 : 281 - 292
  • [10] Cost-effectiveness of insulin detemir compared to NPH insulin for type 1 and type 2 diabetes mellitus in the Canadian payer setting: modeling analysis
    Tunis, Sandra L.
    Minshall, Michael E.
    Conner, Christopher
    McCormick, John I.
    Kapor, Jovana
    Yale, Jean-Francois
    Groleau, Danielle
    CURRENT MEDICAL RESEARCH AND OPINION, 2009, 25 (05) : 1273 - 1284
12345